Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI·NASDAQ

$15.48

-1.5%
HealthcareBiotechnology

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

At a Glance

Live Snapshot
Market Cap$4.38B
EPS-1.9000
P/E Ratio-8.15
Earnings Date06/03/2026

cai

Revenue

Last Annual Value

812.03M

3-Year CAGR

46%

5-Year CAGR

14%

10-Year CAGR

14%

Caris Life Sciences, Inc.

Caris Life Sciences, Inc. Competitors Analysis of Revenue

CAI · NASDAQ
CompanyRevenue
CAGR 3Y
CAGR 5Y
CAGR 10Y
812.03M
38.4%N/A10.7% 
MRNA logo
Moderna, Inc.
NASDAQ:MRNA
1.94B
-34.3%-35.7%33.5%
18.62M
24.9%14.8%N/A
88.04M
127.0%4.6%-1.9%
761.41M
16.4%15.8%25.1%
958.40M
N/AN/AN/A
4.27B
3.6%6.6%11.1%
1.40B
19.0%25.8%25.3%
189.76M
34.8%126.9%N/A
Caris Life Sciences, Inc.

Caris Life Sciences, Inc. Fair Value Envelope

CAI · NASDAQ

Our analysis suggests that CAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.48, this represents a potential HIDDEN relative to our calculated worth for Caris Life Sciences, Inc..

Intrinsic Value
Current Price: $15.48